New Men B immunisation advice

Following recent high profile stories about child deaths from meningitis B, Public Health England has issued further advice:

Men B immunisation programme

Following recent media coverage about the death of a young girl from invasive meningococcal disease caused by Men B, many GP practices have had queries from parents about the availability of Men B immunisation. 

This information is taken from Public Health England publications and the GOV.UK website (see below for details).

What is the national policy for Men B immunisation?

The Men B immunisation programme started on 1 September 2015 for babies aged 2 months, ie, babies born on or after 1 July 2015.  There was a limited catch-up programme for babies born on or after 1 May 2015.  The routine schedule is for immunisation to be given at 2 and 4 months with the primaries, with a booster at 12 months.

Can I vaccinate children born before 1 May 2015 if parents request it? 

No. The national stock of Bexsero® should only be used to vaccinate children who are eligible for NHS vaccination.

Can I vaccinate children born on or after 1 May 2015 who have not yet been vaccinated?

Yes.  All children in the eligible cohort (ie, born on or after 1 May 2015) remain eligible for Men B immunisation until the age of two years. When Bexsero® has not been given as part of a primary course, give two doses at least two months apart. Those children who have received one dose before their first birthday only require one more dose. Please see the MenB PGD for more information.

If parents ask to pay for Men B immunisation for their children, what should I tell them?

GPs should not charge their own patients (ie, those registered at their practice) a private fee for the vaccine.

Parents seeking the vaccine privately should be made aware that they will be liable for the full costs of the vaccine and any additional administration charges that the private provider may apply. We understand that GSK has supply constraints on the Bexsero vaccine for the private market. Practices must not use centrally-procured stock for the national programme to vaccinate private patients or any patients outside the eligible cohort (other than those at high risk as defined in the green book).

Further information

Last updated : 16 Mar 2016

 

Mword Issue 64 - Dr Michelle Drage's latest update for GPs and practice teams (12 Jun 2020)

This page was updated on 12.06.2020 to clarify that TFL guidance does not currenly include exemptions to wearing face masks, but Department for Transport guidance does.
Read more »

Spring Bank Holiday – 25 May (20 May 2020)

NHS England are currently indicating that 25 May will be treated as a normal bank holiday, so no requirements will be placed on practices to provide additional services because of...
Read more »

Excellence in Supporting Healthcare, ILM certificate aimed at non-clinicians (20 May 2020)

This exciting and newly accredited e-learning course is delivered by the PMA, and normally costs £295. It is based on the competency framework and career pathway and its aim is...
Read more »

Covid-19 mandatory data collection (20 May 2020)

On Friday 15 May 2020, GP practices in England were sent an invitation via the Calculating Quality Reporting Service (CQRS) to participate in a data collection entitled ‘GPES Data for...
Read more »

PCN DES Decision Making Tool (20 May 2020)

Our new decision making tool provides a factually based, critical analysis and risk assessment of the PCN DES for this year, which practices can use to help you make an informed...
Read more »

Coronavirus supplies and 2020 flu vaccination season (20 May 2020)

Having checked with Londonwide LMCs Buying Group suppliers we understand that flu vaccine stock is on track for delivery later this year and that suppliers are currently content that existing orders...
Read more »
Next Page »
« Previous Page